Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Rosa Nouvini"'
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Breast cancer with choriocarcinomatous features (BCCF) is a rare and aggressive breast cancer. BCCF carries a poor prognosis and there is unfortunately scant literature to guide treatment beyond surgical resection with most patients receiving standar
Externí odkaz:
https://doaj.org/article/06b36244c7f04727a79a59a35af0655e
Publikováno v:
CancerREFERENCES. 128(21)
Racial and ethnic minorities (REMs) continue to be underrepresented in clinical trials despite the 1993 National Institutes of Health's Revitalization Act mandating the representation of women and underrepresented minority groups in clinical trials.
Publikováno v:
The Journal of Applied Laboratory Medicine
Publikováno v:
Journal of Clinical Oncology. 39:e18574-e18574
e18574 Background: Minorities continue to be underrepresented in clinical trials despite the National Institute of Health’s Revitalization Act, passed in 1993, mandating the representation of women and underrepresented minority groups in clinical t
Autor:
Amaris Geisler, Dulce M. Barrios, Mario E. Lacouture, Rosa Nouvini, Sarah J. Noor, Gregory S. Phillips
Publikováno v:
Journal of Clinical Oncology. 39:2632-2632
2632 Background: Immune-related cutaneous adverse events (irCAEs) are the most common and often the first toxicity of immune checkpoint inhibitors (CPIs). In the general population, irCAEs occur on average within 3.6 weeks of treatment initiation and
Autor:
Rosa Nouvini
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 56:S36
Autor:
Rosa, Nouvini, Sanjaykumar, Hapani
Publikováno v:
The New England journal of medicine. 368(26)
Publikováno v:
Blood. 128:2210-2210
Intro: Respiratory syncytial virus (RSV) is a common virus that can cause infection in the immunocompromised population.. In patients with hematologic malignancies, mortality rates have ranged from 7% to 83%. Most studies have focused on allogeneic s
Autor:
Rosa Nouvini
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 55:S18
Publikováno v:
Journal of Clinical Oncology. 32:e18519-e18519
e18519 Background: Stage IB non-small cell lung cancer (NSCLC) with visceral pleural invasion (VPI) is felt to be a high risk cancer that may benefit from adjuvant chemotherapy. We hypothesize that...